Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 02, 2023 07:30 ET | Source: Arbutus Biopharma Corporation

Arbutus Reports Fourth Quarter and Year End 2022 Financial Results and Corporate Update

Significant progress made advancing proprietary programs in chronic HBV and Coronavirus AB-729 data from multiple Phase 2a combination clinical trials expected in 2023 Initial Phase 1 data for...
February 16, 2023 07:30 ET | Source: Arbutus Biopharma Corporation

Arbutus to Report Fourth Quarter and Year End 2022 Financial Results and Provide Corporate Update

WARMINSTER, Pa., Feb. 16, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop...